PRESS RELEASE DUBLIN.

Logo design -ttp://photos.prnewswire.com/p. ‘As a head in ladies's healthcare, theU.S. Women's Health Alliancebelieves in offering safe, effective treatment options to our sufferers, and the IUD has become the efficacious forms of contraception on the market,’ saidJack Feltz, MD, President of USWHA and President/CEO ofLifeline Medical Associates, LLCinNew Jersey. ‘The range of women studied in the LILETTA Stage 3 clinical trial is definitely representative of the different population of women treated by our physicians throughoutthe USA.’ LILETTA received marketing approval from theU.S. Food and Drug Administration inFebruary 2015, supported by the largest hormonal IUD trial executed in the U.S.Related StoriesFDA grants accelerated approval for Tagrisso to take care of individuals with advanced NSCLCSausages With Antioxidants From Berries TO AVOID CancerViralytics enters into scientific trial collaboration agreement with MSD As in past years, we are looking towards receiving high quality nominations from researchers in academic and commercial research around the world – – including in the field of biomedical engineering – – and to choosing the 2010 Dr.